KWANG-DONG PHARMACEUTICAL CO., LTD-COMPANY INSIGHT - LIFE SCIENCE ANALYTICS - 2008/07/14 - TF Market Research

Report Overview

Purchase by Section

Search Inside

...Kwang-Dong Pharmaceutical Co., Ltd is a healthca re company engaged in the manufacture of herbal medicines and related products. The company was founded in #### by Soo B. Choi . Its subsidiaries include Kwang Dong Household and Healthcare Inc. and Kwang-Dong Oriental Hospital. Kwang-Dong Pharmaceutical product folio includes OTC, Prescripti on drugs and Active pharmaceutic ingredients, Drinks, Functional food, Traditional health food and others. Its products includes Derma-K(sodium fusidate-moisture dressing), Hythiol-c Premier for skin disorders, Powe racen for constipation, MAZANOR [Mazanol(Mazindol)] for weight loss, Doxifluridine capsule for cancer, B eauracen(Human placenta extract) for symptom relief of climacteric malfunctions, Copolang capsule for cancers, compound drinks, Ginseng drinks, Uni-calcium Gold, kwang-dong Gamma Linolenic Acid Gold, New Chitoo ligosaccharide Alpha, Cervi Pantotrichum Cornu Energy Drink, Kwang dong red ginseng antler won(health food), Kwang...

Source: LIFE SCIENCE ANALYTICS
Author: HARINATHA, G.
Company: KWANG DONG PHARMACEUTICAL CO LTD
Geographic Regions: ASIA, EASTERN ASIA, KOREA, REPUBLIC OF
Non-Billable Page Numbers: 2

Sections
	Title	Starting Page	Number of Pages
	Company Information	1	1
	Kwang-Dong Pharmaceutical Co., Ltd [NonUS -- Symbol : Stock Code Number : 009290 (KSC)]	1	1
	Formation Date: 1963	1	1
	Business Summary	1	1
	Product Glance	3	1
	No of Products	3	1
	Trial Phase	3	1
	Diseasehub Classification	3	1
	Product Summary	4	1
	Condition Treated	4	1
	Trial Phase Source Partner	4	1
	Products	4	1
	Product Details	4	1
	1. Pyeon ja pill Disease Hub Description	5	1
	Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 2. Copolang Disease Hub Description	5	1
	Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 3. Venitol Disease Hub Description	5	1
	Therapeutic Indication Cancer Current Trial M Trial Details Presently it is Last Updated 5/7/2008 5. Tamoxifen KWANG DONG Dis	5	1
	Therapeutic Indication Current Trial Trial Details Last Updated 6. Teroful Disease Hub Description	5	1
	Therapeutic Indication Drug Class Current Trial M Trial Details Last Updated 7. Chito acid 100Q Disease Hub Description Chito	6	1
	Therapeutic Indication Natural immune Current Trial M Trial Details Presently it is Last Updated 4/14/2008 8.2, 4 Diet Fiben	6	1
	Therapeutic Indication Current Trial Trial Details Last Updated 9. Sencodyl Disease Hub Description	6	1
	Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 10. Poweramin Disease Hub Description	6	1
	Therapeutic Indication Current Trial M Trial Details Last Updated 11. Hardy col plus Disease Hub Description	6	1
	Therapeutic Indication Drug Class Current Trial Trial Details Last Updated	7	1
	Corporate Partners	8	1
	Deal Category: Product Date Source	8	1
	Deal Value (in $ MM)	8	1
	Management Profile	9	1
	Soo Boo Choi -- Chairman and Chief Executive Officer	9	1
	Sung Won Cho -- President and Director	9	1
	Hyun Shik Kim -- Managing Director	9	1
	Yong Gwang Lee -- Managing Director	9	1
	Gwa Gyoon Moh -- Managing Director	9	1

Enter the keyword(s) which you would like to search for within this document and click "Search"

TF Market Research
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.